URGN - UroGen surges on updated late-stage data for bladder cancer therapy June, 13 2024 11:21 AM UroGen Pharma Ltd. 2024-06-13 11:21:20 ET More on UroGen Pharma UroGen Pharma Ltd. (URGN) Q1 2024 Earnings Call Transcript UroGen: All Eyes On UGN-102 Urogen files patent suit against Teva over cancer therapy Seeking Alpha’s Quant Rating on UroGen Pharma Historical earnings data for UroGen Pharma For further details see: UroGen surges on updated late-stage data for bladder cancer therapy